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The ability of a living organism to repair the injuries sustained by 
it  is  the  WONDER OF THE WORLD that  always  fascinates  every 
body. The organized manner in which this occurs consists of wonderful 
cascade of events. 
The study of wound healing has undergone dramatic changes 
within the last two decades.  In the past, decisions regarding patient 
wound healing problems were made strictly on an empirical basis and 
based on historical  observations and anecdotes,  in  some instances 
extending back millennia.  Every materials & methods known to man 
has been tested or used to facilitate or accelerate the wound healing.
Nowadays  we  have  various  options  before  us  to  manipulate 
wound healing in many ways.  Our renewed interest in wound healing 
has prompted a reappraisal of its  basic components and how they 
are individually affected by biological, mechanical, and physical forces. 
The ultimate goal  of  clinical  wound  healing  management  is  safe  & 
easy manipulation of the healing process – we are closer to that goal 
than ever before.
The Healing of Skin – the largest organ of the human body is the 
most studied one.  The Department of Burns, Plastic & Reconstructive 
Surgery in our  Govt.  Kilpauk Medical  College Hospital  receives the 
highest  number  of  patients  in  the  city  affected  with  burns  due  to 
various causes.  Here Type I collagen dressing, a form of Biological 
Occlusive skin substitute wound coverage dressing is being used 
regularly.
This study was conducted to  compare the wound healing with 
collagen dressing and conventional dressing with ointment and gauze.
AIM OF STUDY
This Prospective Randomized Controlled study was conducted 
to compare the wound healing with collagen dressing and conventional 
dressing  with  ointment,  gauze-pad  &  bandage,  with  respect  to  the 
following criteria:
• Their efficacy on wound healing in Burns patients
• The ability to prevent infection
• The effect on the morbidity
• The cost effectiveness
WOUNDS AND THEIR MANAGEMENT
The past 2 decades have produced more advances in wound 
care than have the previous 2000 years as a result of rapid expansion 
in the knowledge of the healing process at the molecular level.  The 
coordinated  interplay  of  technology  and  expanding  scientific 
knowledge  has  provided  wound-care  methods  that  have  greatly 
improved the ability to heal  wounds with few complications.   These 
advances serve as a prelude to the impetus that is likely to come in the 
future.
Two broad categories exist for the  classification of wounds: 
Chronic and acute.   Acute wounds undergo a complex interactive 
process involving a variety of cell types that leads to a healed wound. 
Conversely,  chronic wounds have proceeded through portions of the 
repair process without establishing a functional anatomic result.  
The  ability  to  heal  an  injury  is  a  biologic  necessity  for  all  
organisms, with mammals lagging in proficiency when compared with 
lower  life  forms  that  have  the  ability  to  regenerate  differentiated 
structures.   Technology  and  increased  scientific  knowledge  have 
established a  coordinated  interplay  that  has  improved the  ability  to 
manage wounds in a logical manner, and, on occasion, to accelerate 
the  healing  process.   Insight  into  the  complex  chain  of  events 
leading to the formation of scar is a necessity for every individual 
who attempts wound management.
Although  the  wound-healing  process  varies  among  different 
tissue  types,  there  are  more  similarities  than  differences  between 
them.  In this discussion, skin is considered as a representative tissue  
type.  There are also different types of acute skin wounds, including 
incisional  wounds,  partial  thickness  injuries  (Burns)  and  wounds 
involving  significant  tissue  loss.   Different  types  of  wounds  involve 
different phases of the healing process to varying degrees, although 
the phases themselves remain the same.
PHASES OF WOUND HEALING
Healing of an acute wound follows a predictable chain of events. 
This  chain  of  events  occurs  in  a  carefully  regulated  fashion  that  is 
reproducible from wound to wound.  The phases of wound healing are 
overlapping, but are described in a linear fashion for the purpose of 
clarity.  
The five phases that characterize wound healing include 
(1) hemostasis, 
(2) inflammation, 
(3) cellular migration and proliferation, 
(4) protein synthesis and wound contraction, and 
(5) remodeling.
(1) HEMOSTASIS
All  significant  trauma  creates  a  vascular  injury  and  thereby 
initiates  the  molecular  and  cellular  responses  that  establish 
hemostasis.  The healing process cannot proceed until hemostasis is 
accomplished.   Primary  contributors  to  hemostasis  include 
vasoconstriction,  platelet  aggregation,  and fibrin  deposition resulting 
from the coagulation cascades.  The end product of the hemostatic 
process is clot formation.
(2) INFLAMMATION
Though they were described in an Egyptian Papyrus (3000 BC), 
Celsus,  a  Roman writer  of  the  first  century  AD first  listed  the  four 
cardinal signs of inflammation: rubor, tumor, calor, and dolor (redness, 
swelling, heat, and pain).  A fifth clinical sign, loss of function (functio 
laesa),  was later added by Virchow.  In 1793, the Scottish Surgeon 
John  Hunter  noted:  that  inflammation  is  not  a  disease  but  a  non-
specific response that has a “salutary” effect on the host.
  At  the tissue level,  increased vascular  permeability and the 
sequential  migration  of  leukocytes  into  the  extravascular  space 
characterize  inflammation.   One  of  the  primary  functions,  of 
inflammation is to bring inflammatory cells to the injured area.  These 
cells then destroy bacteria and eliminate debris from dying cells and 
damaged matrix so that the repair processes can proceed.
Within 10 to 15 minutes after injury, the endothelial cells lining 
the capillaries in the vicinity of the wound develop gaps between them, 
which permit the leakage of plasma from the intravascular space to the 
extravascular compartment. The migration of fluid into the injured area 
generates  edema,  which  contributes  to  the  sensation  of  pain  that 
characterizes inflammation.
As  the  healing  process  proceeds,  inflammatory  cells  trapped 
within clots are sloughed.  Neutrophils remaining within the wound 
become senescent and undergo apoptosis.  The stimuli that lead 
to  inflammatory  cell  apoptosis  during  tissue  repair  and  scar 
formation have yet to be determined.  Neutrophils are the first of the 
inflammatory cells to become apoptotic.  They are then phagocytosed 
by macrophages.  Macrophages and lymphocytes remain in the wound 
for approximately 7 days and then gradually diminish in number unless 
a noxious stimulant of further inflammation persists.  Inflammatory cell 
apoptosis  influences  antigen  presentation  and  probably  more 
importantly, contributes to modulation of cytokine concentrations.
Cytokines
The wound-healing process is,  in large part,  regulated by the 
ordered  production  of  cytokines  that  control  gene  activation 
responsible  for  cellular  migration  and  proliferation  and  synthetic 
activities.  As mentioned, platelets and macrophages are key cytokine 
sources, although many other cells produce them.  
(3) CELLULAR MIGRATION AND PROLIFERATION
The cellular milieu in wounds changes dramatically in the first 
week post acute injury.  The initial fibrin-fibronectin matrix is heavily 
populated by inflammatory cells, whereas fibroblasts and endothelial 
cells will predominate as healing progresses.  
Re-establishment of the epithelial surface is also initiated within 
the  first  several  days  after  injury,  as  is  revascularization  of  the 
damaged  area.   Cytokine  networks  continue  to  be  a  part  of  the 
process  as  cytokine  release  contributes  to  fibroplasias, 
epithelialization, and angiogenesis.  Although much is known about the 
signals that stimulate the predominant activities during this phase of 
healing, less is known about the signals that bring these activities 
to a controlled end.  Negative feedback mechanisms that deactivate 
cells after they have completed their work are also essential for normal 
healing.
Additional fibroblasts are required in the healing wound, in that 
native cells are lost or damaged in any injury.   Repopulation of the 
wounded area with fibroblasts occurs as a result of fibroblast migration 
from  adjacent  tissues  and  proliferation  of  cells  in  the  wound.   In 
addition,  undifferentiated  cells  in  the  vicinity  of  the  wound  may 
transform into fibroblasts under the influence of cytokines in the wound 
milieu
Angiogenesis
The  angiogenic  process  becomes  active  from  day  2  after 
wounding.  Factors in the wound milieu that contribute to angiogenesis 
include  high  lactate  levels,  acidic  pH,  and,  in  particular,  decreased 
oxygen tension.  The severe degree of hypoxia in granulation tissue 
most likely results from both disruption of the native vasculature and 
increased  oxygen  consumption  by cells  in  the  wound  environment. 
Proliferating cells are known to consume oxygen three to five times 
faster than do cells in resting phases of the cell cycle.
During  angiogenesis,  endothelial  sprouts  derive  from  intact 
capillaries at the wound periphery.  The sprouts grow through cellular 
migration and proliferation.  The endothelial cells develop a curvature 
and  begin  to  produce  a  lumen  as  the  chain  of  endothelial  cells 
elongates.  Eventually, the endothelial sprout comes into contact with 
a  sprout  derived  from  a  different  capillary,  and  they  interconnect 
generating a new capillary.
Epithelialization
Following  acute  injury,  reconstruction  of  injured  epithelium  is 
crucial  for  re-establishment  of  the  barrier  functions  of  the  skin. 
Reconstruction of injured epithelium begins almost immediately after 
wounding.  Incisional skin injuries, with a minimal epithelial gap, after 
initial  injury,  although  larger  wounds  can  take  much  longer  to 
regenerate a neoepithelium.
During the first 24 hours after injury, basal cells present at the 
wound edge elongate and begin to migrate across the denuded wound 
surface.   If  the initial  injury does not  destroy epithelial  appendages 
such  as  hair  follicles  and  sweat  glands,  these  structures  also 
contribute migratory epithelial cells to the healing process.  These cells 
migrate  across  the  wounded  area  essentially  as  a  monolayer. 
Approximately 24 hours after the initiation of cellular migration, basal 
cells at the wound edge and in the appendages, if present, begin to 
proliferate, contributing additional cells to the healing monolayer.  The 
migration  of  epithelial  cells  continues  until  overlap  is  achieved with 
other epithelial cells migrating from different directions.  At that point, 
“contact inhibition” results in cessation of cellular migration.  
If  the  epidermal  basement  membrane  is  intact,  cells  simply 
migrate over it.  In wounds in which it has been destroyed, the cells 
initially begin to migrate over the fibrin-fibronectin provisional matrix. 
As they migrate across the matrix, however, epithelial cells regenerate 
a  new  basement  membrane.   Re-establishment  of  a  basement 
membrane under the migrating cells involves the secretion of tenasin, 
vitronectin, and type I and V collagens.
When contact inhibition is achieved, hemidesmosomes re-form 
between  the  cells  and  basement  membrane,  and  tenasin  and 
vitronectin secretion diminishes.  The cells become more basaloid, and 
further cellular proliferation generates a multi-laminated neoepidermis 
covered  by  keratin.   The  neo-epidermis  is  similar  to  the  native 
epidermis, although it is slightly thinner,  the basement membrane is 
flatter, and rete pegs that normally penetrate the dermis are absent.
(4) PROTEIN SYNTHESIS AND WOUND CONTRACTION
Synthesis and deposition of proteins and wound contraction are 
the wound-healing events that begin to predominate 4 to 5 days after 
wounding.   The quality and quantity  of  matrix deposited during this 
phase  of  healing  significantly  influence  the  strength  of  a  scar. 
Collagen constitutes more than 50% of the protein in scar tissue, and 
its  production  is  essential  to  the  healing  process.   Fibroblasts  are 
responsible  for  the  synthesis  of  collagen  and  other  proteins 
regenerated  during  the  repair  process.   Collagen  synthesis  is  also 
affected by characteristics of the patient and the wound including age, 
tension,  pressure,  and  stress.   Collagen  synthesis  continues  at  a 
maximal rate for 2 to 4 weeks and subsequently begins to slow.
Conversely,  keloid  formation  results  from  excessive  collagen 
synthesis for which a preventative measure has yet to be found.
As mentioned, the initial wound matrix is composed primarily of 
fibrin and fibronectin.  As protein synthesis accelerates, the nature of 
the  wound  matrix  changes.   Collagen  and  other  proteins  such  as 
proteoglycans gradually replace fibrin as primary matrix constituents. 
Proteoglycans are a key component of mature matrix and are actively 
synthesized during this phase of healing.
Collagen makes up 25% of protein in the body and more than 
50% of protein in scar tissue.  The concentration of collagen subtypes 
varies among tissues.  Type I collagen predominates and makes up 
80% to 90% of the collagen seen in intact dermis.  The remaining 
10% to 20% is type III collagen.  In contrast, granulation tissue that 
forms soon after injury contains 30% type III  collagen.  Accelerated 
type III collagen synthesis is correlated with fibronectin secretion after 
injury.   Type  II  collagen  is  seen  almost  exclusively  in  cartilage, 
whereas type IV collagen is found in basement membranes.  Type V 
collagen is found in blood vessels, whereas type VII collagen forms the 
anchoring fibrils of epidermal basement membrane.
Type  I  collagen  consists  of  a  triple  helix  involving  three 
polypeptide  chains  that  are  synthesized  separately  within  the 
fibroblast.  The polypeptide chains consist of a repeating glycine-X-Y 
pattern, in which the X position is often proline and the Y position is 
often hydroxyproline.  The interaction of chains initiates the formation 
of  the  triple  helix,  which  is  secreted  as  “procollagen” into  the 
extracellular environment.  Collagen undergoes eight post-translational 
steps intracellularly  prior  to its  extracellular  secretion in the form of 
procollagen
Wound contraction  begins  4  to  5  days  after  initial  injury  and 
actively continues for approximately 2 weeks.  The process continues 
for a longer period of time in wounds that remain open at the end of 
the  2-week  interval.   In  an  open  wound,  the  results  of  wound 
contraction  are  evident  because wound edges  draw closer  to  each 
other.  In an incisional wound, wound contraction simply results in scar 
shortening  and  is  less  apparent.   The  rate  of  contraction  varies 
between  anatomic locations,  but  averages approximately  0.6  to  0.7 
mm per day.  The rate of contraction can often be predicted by the 
degree of  skin  laxity  at  the wound  site.   A wound on the scalp  or 
pretibial  area  will  contract  significantly  more  slowly  than  a  buttock 
wound.  Wound shape also affects the rate of contraction, with square 
wounds  contracting  more  quickly  than  circular  wounds.   Circular 
stomas  are  therefore  less  likely  to  have  compromised  patency 
secondary to contraction.
Wound  contraction  is  characterized  by  a  predominance  of 
myofibroblasts at the wound periphery.   Myofibroblasts are modified 
fibroblasts that were initially described by Gabbiani et al in 1971.  The 
defining  characteristics  of  myofibroblasts  include  actin-rich 
microfilaments  in  the  cytoplasm,  a  multi-lobulated  nucleus,  and 
abundant rough endoplamic reticulum that can only be discerned by 
electron  microscopy.   The  time  frame  in  which  myofibroblasts  are 
present within the wound does not correspond perfectly to the course 
of wound contraction, although it is fairly close.  Myofibroblasts appear 
4 to 6 days after initial injury and are commonly seen in the wound 
during the ensuing 2 to 3 weeks.  Their disappearance is suspected to 
be via apoptosis.  
Although  Gabbiani  et  al  postulated  that  these  cells  were  the 
“motor”  that  contracted  a  wound;  more  recent  work  with  collagen 
lattices  has  suggested  that  fibroblasts  in  the  central  portion  of  the 
wound may be more critical  to the contraction process.   It  is clear, 
however, that the process of wound contraction is cell mediated and 
does  not  require  collagen  synthesis.   TGF-beta  and possibly  other 
cytokines are involved in the wound contraction process.
Wound contraction is sometimes not a desirable healing event. 
Wound  contraction  across  joints  can  produce  contractures that 
significantly limit function.  In cases in which contraction inhibition is 
preferred, skin grafting, especially with thicker grafts, is used to limit 
contraction.  Splints can also limit undesirable contraction in certain 
anatomic locations if utilized for prolonged periods.
(5) REMODELING
Scar remodeling begins to predominate as the primary wound-
healing  activity  approximately  21  days  after  injury.   The  rate  of 
collagen synthesis diminishes and reaches coincidence with the rate of 
collagen  breakdown.   The down-regulation  of  collagen  synthesis  is 
mediated by gamma-interferon, TNF-alpha, and collagen matrix itself.
The nature of the wound matrix changes with scar remodeling. 
Immature scar contains a disorganized array of fine collagen fibers, 
which is gradually replaced by thicker fibers arranged in an orientation 
paralleling skin stresses.  In addition, the number of cross-links both 
within and between molecules gradually increases.  As the nature of 
the  collagen  matrix  changes,  it  becomes  less  cellular  through 
apoptosis of cells involved in the healing process.  As mentioned, the 
ratio of type I to type III collagen changes, and the quantity of water 
and proteoglycans diminish.  Normal skin shows a basketlike weave 
pattern  that  is  never  completely  reproduced  with  scar 
remodeling.
Although  seemingly  not  as  complex  as  other  aspects  of  the 
healing process, remodeling is essential to the formation of a strong 
wound.   The  remodeling  process  is  associated  with  a  substantial 
increase in wound-breaking strength.   Wound strength 1 week after 
injury is 3% of normal dermis.  After 3 weeks, when the remodeling 
phase begins to predominate, the wound will have only approximately 
20% of  the strength of  normal  dermis.   At  3 months,  however,  the 
wound will have 80% the strength of normal dermis, with the significant 
increase  in  strength  resulting  from  the  contribution  of  remodeling. 
Remodeling will continue for up to 12 months after a wound is created, 
although scars never regain the strength of normal dermis.
DRESSINGS
Dressings  have  been  used  since  antiquity  to  facilitate  the 
healing process.  The choice of which dressing to use for a particular 
wound requires an understanding of tissue repair  and knowledge of 
the properties of available dressings.  There are currently hundreds of 
dressings on the market to aid in wound management.  
Before selecting a dressing for a particular wound, a practitioner  
must assess carefully the needs of the wound to understand which  
dressing would provide maximal benefit.  Frequently, there is not one 
clear  best  choice,  and it  is  crucial  that  the pros and cons of  each 
dressing modality be understood.  
Brief history of dressings
Historically,  wounds  were  treated  with  homespun  remedies 
derived  in  part  from  ritualistic  teachings  and  in  part  from  careful 
observation.  Almost every methods and materials known to man have 
been tried on the wound for enhancing wound healing.  The “three 
healing gestures” were described (circa) 2200 BC on an ancient clay 
tablet: 
(1) washing the wound, 
(2) making  plasters  (mixtures  of  herbs,  ointments,  and oils 
that were applied to wounds to aid in the healing process), 
and 
(3) bandaging the wound. 
The first antiseptic dressings were introduced in 1967 by Lister, 
who soaked lint and gauze in carbolic acid (phenol) before applying 
them to wounds.  True sterilization did not become a available until 
nearly the turn of the twentieth century, however.  One of the earliest 
nonadherent  dressings  was  tulle  gras,  which  gained  popularity  in 
World  War  I  and  consisted  of  gauze  impregnated  with  paraffin. 
Owens  first  discussed  fine  mesh  gauze  as  a  minimally  adherent 
intermediary underlying more absorptive materials in 1944.
Many sophisticated dressings have become available to the 
wound care practitioner more recently.  These newer materials and 
agents supplement older dressing materials, such as gauze, which still 
are  commonly  used.   The decision  of  which  dressing  to  use  for  a  
particular  wound  can  be  challenging  given  the  array  of  products  
available.
Desirable dressing characteristics
Certain  features  are  desired  in  a  dressing  regardless  of  its 
structure and the type of wound on which it is placed, as follows:
• Protect wound from bacteria and foreign material
• Absorb exudates from wound
• Prevent heat and fluid loss from wound
• Provide  compression  to  minimize  edema and  obliterate  dead 
space
• Be nonadherent to limit wound disruption
• Create  a  warm,  moist  occluded  environment  to  maximize 
epithelialization and minimize pain
• Be esthetically attractive
All  dressings  ideally  should  protect  wounds  from trauma and 
contamination by bacteria and foreign material. Dressings also should 
absorb  exudates  generated  by  the  wound.   Another  priority  is  to 
provide compression to minimize edema and obliterate dead space.  In 
most  circumstances,  maintenance of  a warm,  moist  environment  is  
desirable  to  maximize  the  rate  at  which  healing  functions  occur. 
Prevention  of  heat  and  fluid  loss  is  also  important,  especially  in 
wounds covering a large surface area, such as burns.  Nonadherence 
is  generally  desirable  to  limit  disruption  of  healing  tissues  during 
dressing changes.  All dressings should be esthetically attractive.
No  single  dressing  can  provide  all  of  these  functions 
optimally,  and  not  all  functions  are  required  for  all  wounds. 
Different  dressing  materials  provide different  functions  to  greater  or 
lesser degrees, and the  attributes of each dressing material need to 
be matched to the specific wound on which it is placed.
An alternative to the application of a dressing is simply allowing 
a  scab  to  form  on  a  wound.   Scabs  are  nature’s  dressing. 
Essentially, they are crusts of dried serum with trapped erythrocytes, 
platelets, and other blood-borne cells.  Scabs provide many functions  
often provided by dressings, including 
• provision of a barrier against foreign material, 
• reduction of pain, 
• holding the wound edges in approximation, 
• facilitation of wound contraction, and 
• minimizing the loss of fluid and proteins.  
Although  scabs  perform  many  useful  functions,  they  are  not  ideal. 
They slow epithelialization,  and they can fix bacteria on the wound  
surface, which can lead to infection.
SPECIAL WOUND REQUIREMENTS
In some wounds, factors may be present that interfere with normal healing. 
In  these  situations,  the  need  for  a  warm,  moist  occluded  environment  may be 
superseded by the need to eliminate the factors interfering with normal healing.  As 
mentioned, wounds related to infection and wounds that are heavily contaminated 
by bacteria require a dressing that diminishes the bacterial  count  in the wound. 
Placing  an  occlusive  dressing  on  an  infected  wound  encourages  bacterial 
proliferation and exacerbates the infection.
Heavily  exudative  wounds  often  require  a  degree  of  absorption  that  no 
occlusive dressing can provide.  Large amounts of exudates can macerate the skin 
surrounding a wound and dilute intrinsic factors such as cytokines, which promote 
healing.  Absorption of excessive exudates becomes a priority in these wounds.
Dressing regimens that  contribute to wound debridement  are required in 
wounds containing nonviable tissue.  Similar dressings are required in wounds with 
foreign bodies or debris.  In wounds involving toxins, such as brown recluse spider 
bites  or  infiltrated  chemotherapeutic  agents,  debridement  is  required  to  limit 
ongoing  damage by the toxic  agent,  although surgical  debridement  generally  is 
required in these scenarios.
For  wounds  requiring  extensive  debridement,  nothing  surpasses surgical 
debridement in terms of effectiveness.  In wounds in which the surgical approach 
cannot be use4d because of coexisting morbidities or in which the tissue requiring 
debridement is less defined, wet-to-dry dressing changes or enzymatic agents have 
utility.  Enzymatic debridement may be slightly more comfortable for the patient, but 
it involves additional costs.
TYPES OF DRESSINGS
As  mentioned  previously,  no  single  dressing  can  provide  all 
things to all wounds, and the needs of each individual wound need to 
be prioritized.  These needs must be matched to the pros and cons of 
possible  dressings.   Frequently,  there is  not  one clear  best  choice, 
especially  because  most  wounds  have  a  variety  of  needs.   The 
practitioner  must  decide  which  dressing  functions  to  maximize  to 
choose among the possibly acceptable dressing candidates.
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Nonadherent fabrics are derivatives of fine mesh owen gauze 
and tulle gras.  Many of the dressings in this category consist of fine 
mesh  gauze  with  a  supplement  provided  to  augment  its  occlusive 
properties,  its  nonadherent  properties,  its  healing  facilitating 
capabilities,  or  its  antibacterial  characteristics.   There  are  also 
synthetic nonadherent fabrics.  
Nonadherent  fabrics  can  be  divided  into  hydrophobic  and 
hydrophilic dressings.  Hydrophobic fabrics are more occlusive, eg. 
Vaseline gauze.  These materials do not facilitate the drainage of fluid 
through them readily.  Hydrophilic materials  incude eg. Fine mesh 
gauze.  These materials more readily facilitate the drainage of fluid into 
overlying dressing layers.
II. ABSORPTIVE DRESSINGS
Absorption of exudates is a desirable dressing attribute.  A study 
showed that  exudates production from leg ulcers averages about  5 
g/10 sq.cm/24h (range. 4 to 12 g/10 sq.cm/24h).  Exudate collects and 




Wide mesh gauze is excellent at wicking exudates away from a 
wound,  although  it  loses  effectiveness  when  saturated.   Gauze 
commonly is placed over nonocclusive,  nonadhering fabric  dressing 
materials to absorb material draining through them.  Wide mesh gauze 
adheres  to  a  wound  if  placed  in  direct  contact  with  it.   Although 
disadvantageous  for  most  wounds,  this  characteristic  can  be 
advantageous if wound debridement is desired.
Foams
Foam  dressings  consist  of  hydrophobic,  polyurethane  foam 
sheets.   The  advantages  of  foam  dressings  are  that  they  are 
absorbent  and  nonadherent,  and  they  can  expand  and  conform  to 
wounds with unusual configurations.  They are comfortable and can be 
removed easily for cleaning.  
Foam dressings have disadvantages as well.  As wounds heal, 
they need to be replaced with additional dressings that correspond in 
size to the shrinking wound.  Also, they provide limited protection from 
bacterial  contamination.   Because  they  absorb  fluid  from  the 
environment, they cannot be used while bathing.
Epithelialization does not occur as readily under foam dressings 
as under occlusive dressings.  This may be a result  of less precise 
occlusion or possibly mechanical impairment of keratinocyte migration 
created by the irregular foam surface.  In addition, the wicking property 
of foams may leach cytokines from the wound surface.
III. CREAMS, OINTMENTS, AND SOLUTIONS
Many  topical  wound  treatments  are  available  in  the  form  of 
creams,  ointments,  and  solutions.   This  is  a  broad  category  that 
extents  from  time-honored  materials,  such  as  zinc  oxide  paste,  to 
cutting-edge  preparations  containing  growth  factors.   Ointments 
commonly  are  used  on  the  face,  where  creams  have  a  greater 
tendency to run in to the eyes or mouth.
The primary advantage to this approach is that it is simple and 
does  not  interfere  with  function.   Ointment  also  provides  a  moist 
environment,  which  facilitates  epithelialization  and  limits  scab 
formation.  The disadvantages of  this approach are that  it  provides 
limited absorption, protection, immobilization, and compression.  Also 
the ointment can be wiped off inadvertently.  If excessive ointment is 
applied to a wound, it sometimes can become macerated as well.
  Many of the creams, ointments, and solutions are designed to 
have  antibacterial  properties.   Others  include  enzymatic  debriding 
agents.   Still  others  include  free  radical  scavengers  (allopurinol, 
dimethyl sulfoxide), agents to degrease platelet aggregation (iloprost), 
and growth factors (platelet-derived growth factor) or agents that bind 
growth factors (sucralfate).
Silver-based dressings - Silver sulfadiazine
Silver sulfadiazene (Silvadene) was developed in the 1960s by 
Fox.  Silvadene has a broad spectrum of antibacterial, antifungal, and 
aniviral  activity.   Its  limitations are  its  occational  association  with  a 
transient neutropenia and its occasional topical sensitivity.  Although 
fibroblast  toxicity  has  been  shown  for  Silvadene  and Sulfamylon  in 
culture,  it  has  been  noted  to  accelerate  epithelialization  of  partial-
thickness  wounds,  suggesting  that  some  of  the  toxicity  may  be 
buffered by other  wound components  in vivo.   In  other  studies,  an 
increase in neovascularization was noted.  Silvadene has become the 
most commonly used antibacterial agent in burn wound management. 
For  most  bacterially  contaminated  wounds  also,  Silvadene  is  the 
preferred antibacterial in that it is effective against a broad spectrum of 
bacteria and has minimal toxicity.  
IV. OCCLUSIVE DRESSINGS
Currently, occlusive dressings can be divided into two classes, 
non-biologic  and biologic.  Nonbiologic occlusive dressings include 
films,  hydrocolloids,  alginates,  and  hydrogels.   Depending  on  their 
construction, some foam dressings fit in this category as well.  Biologic 
occlusive  dressings  include  allograft,  xenograft,  amnion,  and  skin 
substitutes.
Concept of occlusion
Understanding the concept of occlusion has been fundamental 
to the evolution of wound dressings and has created a paradigm shift 
in the management of  wounds.   Before this understanding,  wounds 
often were kept dry,  as advocated by Pasteur to keep them “germ-
free”.  Winter published his seminal work on the effects of occlusion on 
the rate of epithelialization in 1962.  In his porcine model, surgically 
created wounds were left to heal either open to air or occluded under a 
transparent film.  The rate of epithelialization under the occlusive 
dressing was twofold that of the wounds left undressed.
(1)  Occlusive dressings  limit  the  transmission of  fluids,  water 
vapour, and gasses from the wound bed to the external environment. 
In general, a moisture vapour transmission rate less than 35 g of water 
vapour  transmitted  per  square  meter  of  dressing  per  hour  is 
considered low enough to maintain a moist environment on the surface 
of most wounds.  
Moisture  prevents  desiccation,  which  leads  to  cell  death. 
Moisture  also  facilitates  epidermal  migration,  angiogenesis,  and 
connective  tissue  synthesis.   In  addition,  it  supports  autolysis  of 
necrotic material by providing the solute for enzymatic debridement.
(2)  By  maintaining  an  occluded  moist  environment,  these 
dressings  maintain  a  mildly  acidic  pH  and  a  relatively  low  oxygen 
tension on the wound surface.  These wound characteristics mirror the 
usual early wound environment.  A steep oxygen gradient stimulates 
angiogenesis,  an important  factor  in wound healing.   A low oxygen 
tension also provides optimal conditions for fibroblast proliferation and 
granulation tissue formation.  
(3)  Granulation  tissue formation  and epithelialization  also  are 
encouraged by cytokines, which are more likely to be preserved in an 
occluded wound environment.
(4)  Occlusive dressings  limit  the  pain  associated  with  partial-
thickness  wounds  to  a  much  greater  degree  than  non-occlusive 
dressings.
Films
Film  dressings  are  generally  clear  polyurethane  membranes 
with acrylic adhesive on one side for adherence.  Eg. Opsite.  They are 
waterproof but allow the transmission of oxygen, carbon dioxide, and 
water  vapour.   The degree of  permeability  varies  with  the product. 
Because they are generally transparent, the underlying wounds can be 
visualized easily,  and because they are extremely thin,  they do not 
interfere with patient function.
Film  dressings  have  disadvantages  as  well.   They  are 
nonabsorptive  so  that  exudate  collects  under  them  and  frequently 
leaks out.  This leaking disrupts the antibacterial seal created by the 
dressing in addition to being messy.  Dressing changes frequently are 
required when this occurs.  Another disadvantage is that there need to 
be  intact  skin  surrounding  the  area  being  dressed  for  dressing 
adherence.  This skin may not be available when large donor sites 
are needed, as in burn patients.  Wound contraction may be slowed 
by occlusive dressings, and removal of the dressings can disrupt new 
epithelium.
Hydrocolloids
The term hydrocolloid is used to describe a family of dressings 
containing  a  hydrocolloid  matrix  composed  of  such  materials  as 
gelatin,  pectin,  and  carboxymethylcellulose.   Hydrocolloid  dressings 
are available as adhesive wagers or as pastes or powders. On contact 
with wound exudates, the matrix absorbs water, swells, and liquefies 
to form a moist gel.  Products vary in absorption capacity and may or 
may not leave a residue in the wound.  The ability of hydrocolloids to 
absorb  wound  exudates  differentiates  them from  films.   Otherwise, 
they  share  many  positive  characteristics,  including  limited  moisture 
and gas transmission and impermeability to bacteria.  
Hydrocolloids are generally opaque and are slightly bulkier than 
films.  This increased size may provide more protection for the wound, 
although it may interfere with function to a greater degree.  
Alginates
Alginate dressings are composed of soft, nonwoven fibers of a 
cellulose-like polysaccharide derived from the calcium salt  of alginic 
acid (seaweed).  They have their primary utility in exudative wounds. 
When in contact with wound exudates, the insoluble calcium alginate 
is  partially  converted  to  a  soluble  sodium  salt.   This  conversion 
generates  a  hydrophilic  gel  as  a  by-product.  The  gel  creates  an 
occlusive environment that facilitates healing.  The characteristics of 
the environment under alginate dressings have not been evaluated as 
completely as that under films and hydrocolloids.  When the alginate 
becomes  engorged  and  begins  to  “bleed”,  a  dressing  change  is 
indicated.   Alginates  are  packaged  in  a  variety  of  forms,  including 
ropes for packing cavities, ribbons for narrow wounds or sinuses, and 
pads. 
Hydrogels
Hydrogel  dressings  consist  of  a  starch  polymer,  such  as 
polyethylene  oxide,  or  a  carboxymethylcellulose  polymer  and  upto 
80% water.  They are available as gels, sheets, or impregnated gauze. 
They function as rehydrating agents for dry wounds.  Because of their 
high  water  content,  they  do  not  absorb  large  amounts  of  wound 
exudates.  They do create an occlusive environment underneath them, 
although the  characteristics  of  the environment  have not  been well 
worked out.
COMPARISONS OF NONBIOLOGIC OCCLUSIVE DRESSINGS
There  are  significant  differences  between  different  types  of 
nonbiologic occlusive dressings.  There are also differences between 
different products in each category.  Although similar in appearance, 
the  dressings  differed  markedly.   Thickness,  absorption,  moisture 
vapour  permeability,  conformability,  residual  supernatant  pH,  fluid 
retention, and gel cohesion all varies from product to product.  There 
are significant differences in the levels of occlusion produced.  
Bradley and coworkers performed a meta-analysis of dressings 
and topical agents used for pressure sore treatment.  No significant 
differences  were  noted  between  polyurethane foam dressings,  film 
dressings, hydrocolloid dressings, or various membrane dressings  in 
their effects on healing.
Although  there  are  differences  in  handling  characteristics, 
adherence,  dispersion  of  wound  exudates,  and amount  of  dressing 
residue left on the wound,  they do not differ significantly in their 
effect on epithelialization or dermal healing.
There is evidence that each of the occlusive dressings facilitates 
healing  and  limits  pain  to  a  greater  degree  than  non-occlusive 
dressings.  It is difficult to state that one occlusive dressing provides 
these attributes better than another,  however.   The choice of which 
occlusive dressing to use for a particular wound is predicated primarily 
on  other  factors.   Hydrocolloid  and  alginate  dressings  generally 
provide more absorption than either hydrogel dressings, which provide 
limited absorption, or films, which are non-absorptive.  
Films are transparent and allow wounds to be visualized.  None 
of  the other  occlusive dressings  provide this  benefit.   The film and 
hydrocolloid  dressings  include  adhesives.   They  generally  adhere 
better than hydrogels or alginates but require surrounding skin that is 
intact  to  which  to  adhere.   This  ability  to  adhere  allows  films  and 
hydrocolloids to protect wounds better from contamination by bacteria 
and foreign materials but may contribute to more disruption of healing 
tissues with dressing changes.
Biologic occlusive dressings
As mentioned, biologic dressings include homograft, xenograft, 
and amnion.  Homograft  is a graft  transplanted between genetically 
unique humans, whereas a xenograft is a graft transplanted between 
species.  Pigskin is the most commonly used xenograft.  Homografts 
and xenografts are  temporary dressings in that both are rejected if 
left  on  a  wound  for  an  extended  period.   Amnion  is  derived  from 
human placentas and is another effective biologic wound dressing.  Its 
use  has  diminished  with  increased  concern  regarding  biologic 
materials.
Wound Coverage vs Wound Closure
Wound closure materials are biologically accepted by the wound 
bed & become permanently incorporated into the healing wound.  On 
the other hand, wound Coverage materials rely upon incorporation into 
the wound coagulum & ingrowth of granulation tissues for adhesion; 
this phenomenon is characteristic of many wound coverage materials. 
These materials in general  do not biodegrade & therefore they can 
only be temporary substitutes & must be replaced with the patient’s 
skin  either  by  re-epithelialization  or  skin  grafts.   In  the  case  of 
temporary coverage, the wound should not be colonized with bacteria 
&  it  should  be  sufficiently  superficial  that  it  is  expected  to  heal 
completely  within  3  weeks.   Epithelial  cells  from  the  epidermal 
appendages grow & replace the destroyed epidermis and gradually the 
wound coverage material is shed.  Therefore, the primary goals for the 
wound coverage materials in Superficial Second degree wounds are: 
to limit the microbial invasion of the wound bed (microbial barrier) & 
thereby to prevent  infection;  to limit  the access of  air  & thereby to 
minimize pain.
Wound coverage materials have been used temporarily for deep 
second or third degree injuries prior to definitive wound closure with 
autologous skin in Patients with massive burn injuries.  Unfortunately, 
this  strategy  frequently  fails  because  underlying  devitalized  burn 
tissues routinely  lead to contained infections when used with  these 
deeper burn injuries. 
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wound bed
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* Incorporates into wound coagulum & granulation tissue
^ Wounds exposed to completely heal within 3 weeks
#  The  new  epidermis  migrates  between  the  foreign  material  & 
eliminates it
Wound closure Materials:
Dermal matrix strategy – eg. Biobrane, Integra, Eucoll, Healicoll 
(totally acellular)




Collagen  is  a  biological  protein  with  a  unique  chemistry  and 
multiple physiological functions.  It is a natural biomaterial, which has 
many responsibilities in the body, such as aiding cellular activity and 
providing an organized matrix in most tissues including skin.
Collagen  is  a  large  protein  molecule  (app.  300,000mw) 
containing simple amino acids like alanine, glycine and hydroxyproline. 
Among the different types of Collagen,  Type-I collagen is known to 
be  less  antigenic.   At  molecular  level,  collagen  tends  to  attract 
undifferentiated stem cells and convert them into appropriate cell types 
for proper remodeling of the tissue under repair.  Its unique chemical, 
structural,  mechanical  and physical  properties  form an environment 
conducive  to  wound  healing  and  ultimately  wound  closure,  thus 
making it the most ideal natural biomaterial of choice, in health care.
Collagen  has  been  used  as  filling  material  for  orthopaedic 
applications and in different forms for dental applications.  Collagen 
shields  and  gels  have  been  extensively  used  for  various 
ophthalmological applications.  It is also used as a hemostatic agent 
besides being used as various prosthetic implants.
There are two types of collagen sheets are commonly available 
in the market for wound covering.   Wet collagen was the one first 
introduced.  It was stored and transported in FORMALIN.  Therefore it 
has to be washed well  with normal saline before application on the 
wound.   Otherwise,  there  will  be  severe  burning  sensation.   Dry 
collagen came into the market later.  This has the advantage of direct 














          Wet Collagen Needs preparation before application. (to 
be pre-washed)
          Dry-Collagen 
(Healicoll)
Ready to use, ease in application, flexible 
&  tackiness,  cover  the  wound  properly, 
ease  of  application.  Being  transparent 
enables monitoring of the wound without 
disturbing the healing  process.  Provides 
hemostasis,  High  patient  comfort, 
Economical
What is Healicoll-M?
• It  is  commercial  product  of  DRY  COLLAGEN  produced  by 
Advanced Biotech Products (P) Ltd.  (They can be contacted @ 
www. advancedbiotech.org)
• It  is the reconstituted collagen sheet free of contaminants like 
lipids, elastin and other immunogenic proteins.
• It  is  derived  from  selected  animal  tissues,  using  a  patented 
process from US to obtain high quality collagen type I.
• It is processed under GMP conditions and stringent USP quality 
test as per international standards.
• It  is transparent and dry membrane with unique advantage of 
flexibility and moderate tackiness.
• It  is  presented with  a backing sheet,  individually  packaged in 
synthetic micro porous paper pouch and is gas sterilized
Directions of Use
• No  pre-treatment  is  needed  for  application  of  dry  collagen 
(Healicoll) or wet collagen.  It is ready to apply.
• Clean the application site thoroughly with povidone iodine or any 
other antiseptic.
• Do not apply ointment or any greasy cream on the site prior to 
dry collagen
• Peal  open  the  pouch  and  directly  apply  the  collagen  on  the 
cleaned wound.  Do not mesh the collagen. 
• Do not try to over stretch the membrane.
• You can apply collagen on either of its surface and it adheres to 
the wound instantly.
• In  case of  dry  wounds,  sprinkle  sterile  saline solution  on the 
surface and apply.
• Gently  press  the  membrane  with  gauze  soaked  in  saline, 
especially around the edges for better adhesion.
• Repeated dressing is not required, unless the wound is infected.
• Collagen wound cover is transparent – hence we can monitor 
the healing – without peeling off the membrane and thus avoid 
disturbing epithelialization.
• The collagen peels off as the wound heals.  However, in some 
circumstances it may need to be moistened with saline before 
removal.
• In ulcers, the necrotic tissue should be removed and the sheet 
should be applied on granulation of the tissues.
• In case of localized bulging of collagen after application due to 
fluid accumulation beneath, a small incision can be made at the 
site  and  exude  the  fluid.  This  incision  can  be  sealed  with 
additional small piece of collagen, which adheres firmly with the 
already  applied  sheet.   Alternatively,  to  avoid  such 
inconvenience, meshed type of collagen is also available, where 
the excess fluid is released automatically.   The same can be 
used for donor site application also.
• For  donor  site  application,  after  surgical  removal  of  donor 
tissue, arrest bleeding by conventional methods, clean the site 
and apply collagen. This avoids repeated dressing.
• Concurrent  systemic  therapy  may  be  given  as  prescribed  in 
infected cases,  leprosy and non-infected cases for better  and 
faster results.
Uses:
As Single Application  
• First or Second degree burns
• Non-infected or Pre-cleaned burns
• Trauma with skin loss
• Chronic skin ulcers
• Skin donor sites
• Amputation sites
Repeated Application 
• Covering material for bedsore
• Diabetic and other type of ulcers
REVIEW OF LITERATURE
1. CONVENTIONAL DRESSING
The traditional approach of dressing is to use three layers – a 
contact layer, an absorptive layer, and a binding layer.  The contact 
layer  is  the layer  in contact  with  the wound itself.   A nonadhering, 
hydrophilic material, is optimal to facilitate drainage into the overlying 
dressing  layers  and  minimally  interfere  with  healing  tissues.   The 
second  absorptive layer generally consists of gauze-pad that wicks 
wound exudates away from the wound to limit maceration.  The outer 
binding  layer fixes  the  dressing  in  place  and  may  provide 
compression and immobilization.  Tape is most commonly used.
The advantages of the three-layer dressing are that it protects 
the wound and absorbs wound exudate well. Wound compression and 
immobilization can be provided to a variable degree depending on the 
binding layer used.  There are several disadvantages to this approach, 
however.   The  relatively  dry  environment  is  not  optimal  for  wound 
reepithelialization.   The  dressings  frequently  are  bulky  and 
cumbersome  for  the  patient.   The  dressings  cannot  handle  an 
unlimited amount of drainage and lose their effectiveness if they soak 
through.
2. COLLAGEN DRESSING
Collagen  is  a  biological  protein  with  a  unique  chemistry  and 
multiple physiological functions.  It is a natural biomaterial, which has 
many responsibilities in the body, such as aiding cellular activity and 
providing an organized matrix in most tissues including skin.
Commercially manufactured Type I  collagen sheets has been 
used for wound coverage.  The following are a few quotes from the 
literature about commercially available collagen and its uses in wound 
healing, especially in Burns.
Journal name : British Journal of Community Nursing
Edition : 2005 Sep.10(9): S31-4
Authur name : King S et al, Basingstoke, UK.
Topic : Catrix: an easy-to-use collagen treatment for     wound healing.
Collagen plays a major role in wound healing. Its presence is 
important in all stages of the healing process. Catrix is a new collagen 
wound-healing  powder  that  has  been  shown  to  be  effective  in  the 
treatment  of  wounds healing by secondary  intent  such as pressure 
ulcers, venous stasis ulcers and diabetic ulcers as well  as  second-
degree burns and post-radiation dermatitis. 
Catrix has also been shown to be effective in the treatment of 
wounds  unresponsive  to  conventional  treatments.  It  promotes  the 
growth of fibroblasts and keratinocytes in the wound, prevents loss of 
fluid from the wound and protects the wound from bacterial infections 
and  other  agents.  Catrix  is  biodegradable  and  therefore  does  not 
require removal from the wound bed before re-application.
Journal name : Burns
Edition : 1990 Dec;16(6):457-61
Authur name : Yang JY et al, 
Linkou  Burn  Unit,  Department  of  Plastic 
Surgery,  Chang  Gung  Memorial  Hospital, 
Taipei, Taiwan, Republic of China.
Topic :  Clinical  application  of  collagen  sheet,  YCWM,  as  a   burn 
wound dressing.
In  the  Linkou  Burn  Unit,  a  recently  developed  new  wound 
dressing  derived  from  porcine  skin  was  evaluated.  This  newly 
designed  porcine  dressing,  called  young  collagenous  wettable 
membrane (YCWM), was developed by the staff of the Department of 
Cellular  and  Molecular  Biology  of  Chang  Gung  Memorial  Hospital. 
Many  specific  characteristics,  such  as  negligible  antigenicity, 
semitransparency, sterilizability, good pain relief and low costs, have 
been associated with it. The results of a clinical trial on 59 wounds on 
50 burn patients proved encouraging.  Some disadvantages such as 
maceration  and  delayed  eschar  separation  were  noted.  They 
concluded that YCWM is suitable for the treatment of the clean, dry 
donor sites and  superficial partial skin loss burn wounds of non-
infected, non-immunocompromised patients.
Journal name : Aktuelle Traumatol
Edition : 1992 Oct.22(5):214-8
Authur name : Goudarzi  YM, Khodadadyan C, Hertel P
Topic : Clinical experience with collagenous wound dressing in severe 
traumatic soft tissue injuries
They  treated  34  patients  during  1987-1990  with  a  collagen 
wound dressing. Eleven patients had traumatic soft tissue defects, 10 
patients had 3 degrees-grade open fractures, 7 patients had infected 
soft  tissue  wounds  and  6  patients  had  deep  2nd degree  and  3rd 
degree  burns.  Their  clinical  experience  confirmed  the  excellent 
clinical experimental results of collagen wound dressings. In all cases 
after 4 until 6 days of treatment, good granulation and vascularisation 
of  the wound bed was obtained,  so that  a skin transplant  could be 
performed, which in all cases healed primarily. Moreover, the wound 
dressing had a good antibacterial effect and integrated actively in 
the wound healing process.
Journal name : Int. J Tissue React 
Edition : 1992;14 Suppl:27-34
Authur name : Mian E, Martini P, Beconcini D, Mian M
Dermatological clinic, University of Milan, Italy.
Topic :  Healing  of  open  skin  surfaces  with  collagen  foils.
Applications  of  Condress  (patented  sheets  of  pure  bovine 
collagen) on open skin surfaces (30 cases of "ulcus cruris", 5 cases of 
decubitus, and malum perforans; 10 cases of  full-thickness burns) 
were  examined  in  a  controlled  trial.  Quantification  of  regeneration 
speed, macro-photographic survey of granulation tissue and epithelial 
border,  thermographic  and  chromometric  evaluation  of  the  skin 
microcirculation, and histological observation of regenerating tissues, 
were  the  parameters  used.  The  following  results  were  obtained: 
marked reduction of healing time, different aspects of the granulation-
tissue responses,  different  times of  topical  collagenolysis,  increased 
vascular  perfusion,  histological  activation  of  angiogenesis, 
fibrogenesis,  histiomacrophage  function  and  superficial  absorption. 
The  employment  of  Condress  in  burn  areas  seems  to  be  highly 
promising.
Journal name: Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi 
Edition : 1993 Jul. 9(4):284-5, 319.
Authur name : Gao ZR et al.
Department of  Burn Surgery,  Affiliated Hospital  of 
Qinghai Medical College.
Topic :  Early coverage of  deep partial-thickness burn wound with 
porcine  dermal  collagen  membrane.  An  experimental 
study
Collagen was extracted by pepsin digestion from porcine skin 
and collagen membrane was prepared by salt precipitation. Collagen 
membrane  as  a  wound  dressing  was  evaluated  in  a  deep  partial-
thickness burn wounds in a rat model. Burn wound, 4 x 4 cm, were 
inflicted by exposing skin to 75 degrees C for 15 seconds followed by 
de-epithelization.  Wound  healing  was  assessed  by  plenimetry  of 
epithelization on day 10 postwounding. Open wounds exhibited a re-
epithelialization  of  24%  of  wound  area.  Collagen  membrane 
dressing significantly improved the healing rate to approximately 
70% of wound area.
PATIENTS AND METHODS
This Prospective Randomized controlled study was conducted in 
the Department of Burns, Plastic & Reconstructive Surgery in the 
Government  Kilpauk  Medical  College Hospital,  during  the period  of 
April 2004 to March 2006 for 2 years.  
Most, if not all the burns victims in this city are being brought to 
this  hospital  and the study was  conducted on these patients.   The 
study was designed to test the efficacy of Type I Collagen dressing in 
hastening wound healing.
To start with,  a  protocol was formulated and  proforma chart 
constituted.  According to the protocol, burns patients on arrival to the 
hospital, were resuscitated and their general condition was stabilized. 
Then they were assessed clinically by the Burns Surgeon as to:
• %  Body  Surface  Area  involvement  –  using  Lund  &  Browder 
Chart 
• The Degree of Burns
• Whether to be treated as Out Patient or In Patient
• Mode of treatment – collagen dressing or conventional method
Suitable samples were selected as per the inclusion criteria and 
necessary exclusions were made as per the exclusion criteria given 
below:
Inclusion criteria
• Patients  who  sustained  burns  in  10  to  40% of  Body Surface 
Area were included in the study.
• Patients with  Superficial  Second degree burns were included. 
These wounds are expected to heal completely within 3 weeks 
without any surgical intervention.
• Patients who were of age below 40 years were included in the 
study.
• Patients who came to the hospital within 24 hours of sustaining 
the burns were included.
• Patients  who  sustained  burns  over  extremities  &  body  were 
preferred.
• Patients who were  literate  & who were  expected to come for 
regular follow-up were preferred.
Exclusion criteria
• Patients with more than 40% BSA burns were excluded from the 
study because of prevailing high mortality rate.
• Patients  with  less  than  10% BSA burns  were  also  excluded, 
because they were treated as Out patients and they were not 
expected to come for regular follow-up.
• Deep second degree & third degree burns were excluded, since 
these wounds will heal only with Partial thickness skin grafting.
• Elderly  people  were  excluded  due  to  comorbid  conditions 
coming into play in them, which might alter the wound healing.
• Patients  who  came 24 hours  after  sustaining  the  injury  were 
excluded  since  these  wounds  might  have  already  become 
infected.   Some  of  these  patients  might  have  been  treated 
outside  & already  become unsuitable  for  collagen  application 
because of the previous treatment modality followed earlier.
• Patients who were not expected to come for regular follow-up 
were excluded from the study.
The patients thus selected were enrolled into the study along with 
their consent.  Thus a total of 100 patients were studied in which 50 
patients who were randomly allocated into the Experimental group 
& were treated with Collagen dressing while 50 others of the Control 
group were  treated  with  conventional  dressing  with  Silver  Sulpha 
Diazene ointment, gauze-pad & bandage dressing.
All the patients were admitted to the burns ward.  The admission 
policy prevailing in our hospital was that burns patients with more than 
10% BSA involvement were to be treated as In patients.
Treating the control group
The patients were resuscitated with IV fluids and their general 
condition improved.  They were kept nil per oral.  They were taken to 
the Burns operation theatre.  Under anaesthesia, the dead skin was 
pealed off and the wound was cleaned well with normal saline.  No 
antiseptics were used over the wound.  Silver sulpha diazene ointment 
was applied over the cleaned wound and an occlusive dressing was 
applied with gauze-pad and roller bandage.  They were brought to the 
wards.  Oral fluids were started as per the general condition.  
The patients were asked to take bath with liquid soap, once in 
every two days and then the dressings were changed along with the 
application of ointment. 
Treating the Experimental Group
The patients were resuscitated with IV fluids and their general 
condition improved.  They were kept nil per oral.  They were taken to 
the Burns operation theatre.  Under IV sedation, the dead skin was 
pealed off.  The wound was cleaned well with normal saline. 
Two  types  of  Type  I  collagen  dressings  were  used.   Wet 
collagen sheets were washed well with normal saline and then applied 
over the wound.  Dry collagen sheets were applied over the wound 
without washing.  This is one of the advantages of the dry collagen. 
Both  of  them  were  not  meshed.  The  collagen  sheets  were  gently 
spread evenly over  the skin wound  with  the back of  the dissecting 
forceps.  The collagen dressing was allowed to dry.  The collagen gets 
adherent to the skin wound in few hours.  The patient was brought to 
the wards and was asked not to move till the collagen dries off.  Slowly 
the patient was mobilized.  They were started on oral fluids first and 
normal diet was resumed as decided by the Burns Surgeon.  
The patients were asked to take bath after 12 to 14 days.  The 
applied collagen dressing was allowed to peel  off  by itself  after the 
wound had fully epithelialized and healed.  Sometimes the collagen 
might have to be trimmed when it does not come off by itself.
Antibiotics  were  prescribed  to  the  patients  according  to  the 
Antibiotic schedule of  our burns unit.   First,  antibiotics were started 
empirically.   Then  the  antibiotics  were  changed  every  weekly, 
according to the prevailing strain of bacterium and its sensitivity.
Within a few days, when they were fit for discharge as assessed 
by the  Burns  Surgeon,  they  were  discharged.   They were  advised 
regular follow-up in the Out Patient department.
All these patients were followed up regularly in the OPD.  The 
control group was reviewed once in every two days for changing the 
dressing along with application of ointment.  For the next two weeks 
Post-Burn, all the patients were reviewed once weekly.  Any difference 
in wound healing was managed appropriately.
After the wound had completely epithelialized and healed well, 
the patients were advised to review once a month for one year in order 
to assess and manage any late complications like hypertrophic scars, 
contractures,  & Keloids.
All the data were collected in the Proforma.  They were formulated 
in a Master chart given behind.  The clinical data thus formulated were 
assessed.
• The efficacy on wound healing was assessed according to the 
time taken in both groups for complete wound healing.
• The ability  to  prevent  infection  was  assessed clinically  in  the 
Experimental  group  by  the  collection  of  pus  underneath  the 
collagen, erythema of the skin, and systemic manifestations like 
fever.  If pus collected under collagen dressing, it was drained 
and  another  collagen  sheet  was  reapplied  over  the  previous 
one.  In the control group, it was assessed by taking bacterial 
swab after 24 hours, 7 days (and 14 days if needed).  
• The effect on the morbidity of the patients was assessed by Pain 
experienced  by  the  patient  (subjective),  Oozing,  Smell,  early 
mobilization and the ability of the patient to take care of his day-
to-day activities by himself.
• The  cost-effectiveness  was  assessed  by  the  number  of 
dressings  needed  to  apply  for  the  patients.   Generally,  the 
experimental group needed only a single sitting of dressing with 
the  collagen  material.   Whereas  the  control  group  needed 
dressing  once in  every  two  days  as long as the wound  gets 
completely epithelialized. 
OBSERVATION & RESULTS
Most  of  the  patients  in  the  experimental  group  showed 
accelerated wound healing as seen from the table.  In more than 90% 
of cases, the burn wound completely healed within 12-14 days.   In 
more than 50% of the Control group, wound healing got delayed.
The most common inhibiting factor causing the delay in wound 
healing  was  INFECTION.   96% of  the  Experimental  group  had  no 
infection.  In the control  group, 52% got infected with the prevailing 
hospital acquired strains of bacteria.
28% of  the  Experimental  group  experienced  pain  due  to  the 
burn wound & it  progressively improved in its severity.   88% of the 
Control  group  experienced  pain.   This  is  more  due  to  repeated 
dressing changes.    About  70% in the Control  group suffered from 
increased oozing & smell from the wound whereas the Experimental 
group was devoid of these problems.
Most  of  the Experimental  group could be mobilized early and 
they took care of their daily needs by themselves.  The patients of the 
Control group had difficulty in early mobilization & were dependent on 
their close relatives for their personal needs in their early post burn 
days.
One patient in the Experimental group expired on the 3rd post 
burn day due to MODS.  His urine output decreased first and Urea & 
creatinine rose slowly.   The renal  failure was managed but  in vain. 
Following  this,  his  general  condition  slowly  deteriorated  and  he 
expired.   The  possible  mode  of  death  was  declared  as  -  due  to 
Septicaemia.
One patient  each from both  the  groups  lost  follow-up.   They 
could  not  be  reached by post  &  person,  in  spite  of  repeated  such 
attempts.  They happened to be living in rented houses.  They shifted 
their  residence during the follow-up period after  the unfortunate fire 
accident.
Three patients in the control  group underwent  Split  Thickness 
Skin  grafting  because of  delayed  wound  healing  & took more than 
double the time for completion of wound healing process.
The results of the study were tabulated as follows:
TIME TAKEN FOR COMPLETE WOUND HEALING
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Collagen dressing Conventional dressing
Absent Present Absent Present
Pain 36 14 6 44
Ooze 49 1 32 18
Smell 49 1 29 21
Early Mobilization 2 48 12 38
Capacity to take 
care of personal 
needs
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DISCUSSION
This Prospective Randomized Control study was conducted to 
know the  efficiency  of  Type  I  Collagen  Wound  Cover  dressing  as 
compared  to  the  Conventional  modality  of  dressing  with  ointment, 
gauze-pad & bandage.
With respect to the effect on wound healing:
90%  of  the  Experimental  group  attained  complete  wound 
healing in 12 -14 days whereas in the Control group, it took 16 -26 
days even in the absence of infection.  It was already proved beyond 
doubt by Winter in 1962 that  the rate of epithelialization under an 
occlusive  dressing  was  twofold  than  that  of  the  wounds  left 
undressed.
Here, even though both type of wound dressings used in this 
study  are  Occlusive  dressings,  they  showed  difference  among 
themselves  in  acceleration  of  wound  healing.   This  is  due  to  the 
inherent  properties  of  the  Type I  Collagen  dressing.   The collagen 
sheet  when  applied  over  the  wound  forms  a  base  for  the 
epithelialization to occur.  This is not provided by the ointment, gauze-
pad  &  bandage  dressing.   Collagen  withholds  the  vital  exudates 
coming  from the  wound,  which  is  rich  in  cytokines  that  accelerate 
wound healing in an acute wound.  This exudate gets wigged away 
from the wound in the conventional dressing.
The  burn  wounds  of  the  patients  in  the  control  group  were 
invariably contaminated due to bacterial colonization as compared to 
the experimental group.  52% of the control group had wound infection 
where as 96% of the experimental group did not.  Infection was the 
most important factor that delayed the healing of wound in the control 
group.
The  morbidity  suffered  by  the  control  group  was  worth 
mentioning.  These patients had wound infection, increased oozing & 
smell from the wound.  They experienced more pain, especially while 
taking bath and changing the dressing.  They could not be mobilized 
early and so this led to these patients being dependant on their close 
relatives for their daily personal needs.  The experimental group did 
well in this respect.  They had no dressing changes; they experienced 
less pain.  They had no or least ooze & smell from the wound.  They 
could be mobilized early.   These patients were able to take care of 
themselves without the help of their close relatives.
Regarding the cost factor, even though Type I Collagen dressing 
appeared costly initially,  this  actually is less when compared to the 
control group.  The cost of the dressing materials, the man-power for 
its preparation & application,  the income loss incurred by the close 
relatives when they had to accompany the patient to the department 
for dressing – all taken together works out to be much more costlier 
when compared to the cost of the collagen treatment.  The comfort 
experienced by the collagen group is the most attractive aspect to be 
stressed in this study. 
PITFALLS OF THE STUDY
This prospective randomized control study had its own pitfalls.
• Blinding was not possible in this study because the difference in 
treatment is very well obvious. Therefore Subject variation bias 
is inevitable.
• Two patients lost follow-up.  This happened and was inevitable 
in spite of all measures taken to prevent this by sending letters 
and persons.
• One patient in the Experimental group expired on the 3rd Post 
burn day due to MODS.  This was paradoxical when compared 
to other patients in the experimental group who did well when 
compared to the control group.
CONCLUSION
Collagen  wound  cover  dressing,  when  compared  to 
Conventional  dressing  with  Silver  Sulpha Diazene ointment,  gauze-
pad & bandage,
• Accelerates the wound healing and thereby reduced the hospital 
stay
• Prevents the incidence of Infection
• Reduces the morbidity suffered by the patients
• Cost effective
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Name : Age : Sex :
AB No. : Educational Status :
% BSA Burns : Address for Communication 
with Phone No.
Degree of Burns :
Etiology : Burns Scalds Electric Radiation
Type of Injury : Accident Suicide Homicide 
Time of Accident :
Time of Admission:
Time of Application of Dressing 
Type of Dressing: Collagen Conventional
Time taken for Complete Healing : Days 
Wound Infection : Present  / Absent 
Morbidity : Pain   Present / Absent 
Ooze   Present / Absent
Smell  Present / Absent 
Mobilization :   Early  / Late
Personal  Care :   Self / Help
Number of Dressing Made :
Remarks (if any)
ABBREVIATIONS
AB no. : Accidental Burns Number
IP no. : In Patient Number
% BSA : Percentage of Body Surface Area





EM : Early Mobilization
DA : Able to take care of their Day-to-day Activities







No. Name AB No. IP No. Age Sex %BSA Dressing CWH Inf
Morbidity
Pn Oz Sm EM DA
1 Subramani 316/04 7158 24 M 24%  - Collagen 12 A A A A P P
2 Susheed 330/04 7526 35 F 20% Ointment - 14 A P A A P P
3 Eswari 342/04 7841 34 F 20%  - Collagen 14 A P A A P P
4 Govindan 356/04 7926 17 M 11% Ointment - 16 A A A A P P
5 Kasthuri 366/04 8346 35 F 27%  - Collagen 12 A A A A P P
6 Chandran 380/04 8623 26 M 33%  - Collagen 12 A A A A P P
7 Manohar 392/04 8956 25 M 20% Ointment - 24 P P P P A A
8 Jamuna 407/04 9287 14 F 23%  - Collagen 14 A P A A P P
9 Divya 418/04 9658 12 F 17%  - Collagen 12 A A A A P P
10 Thirumaran 432/04 10042 24 M 15% Ointment - 16 A P P A P P
11 Peter Muthu 445/04 10532 35 M 17% Ointment - 26 P P P P A A
12 Moorthy 449/04 10823 18 M 26% Ointment - 18 P P P A A P
13 Ayesha 460/04 11411 25 F 34%  - Collagen 14 A A A A P P
14 Kulshar Begam 468/04 11625 23 F 35%  - Collagen 14 A P A A P P
15 Thirumaran 480/04 11862 30 M 14% Ointment - 26 P P P P A A
16 Narasimhalu 489/04 12025 25 M 25% Ointment - 16 A P A A P P
17 Kaliappan 498/04 12563 37 M 16% - Collagen 14 A P A A P P
18 Maheshwari 511/04 13241 11 F 14% - Collagen 12 A A A A P P
19 Praveen 532/04 13921 21 M 30% Ointment - 14 A A A A P P
20 Gayathri 541/04 14354 28 F 30% Ointment - 16 A P A A P P
21 Kuppan 560/04 14586 30 M 17% Ointment - 20 P P A P P A
22 Maragadham 561/04 14602 10 F 15% - Collagen 14 A A A A P P
23 Nazeema 569/04 15245 32 F 30% - Collagen 12 A P A A P P
24 Prabakaran 580/04 15864 35 F 10% Ointment - 12 A A A A P P
25 Kavya 591/04 16260 12 F 18% - Collagen 12 A A A A P P
26 Suresh# 625/04 17350 21 M 26% - Collagen xx A P A A A A
27 Nirmala 663/04 17865 28 F 18% Ointment - 24 P P P P A A
28 Prabha 689/04 18562 30 F 18% Ointment - 16 A P A A P P
29 Valli 709/04 19245 26 F 15% - Collagen 12 A A A A P P
30 Selvi 722/04 19952 36 M 10% Ointment - 16 A P A A P P
31 Vijayalakshmi 739/04 20468 24 F 34% - Collagen 14 A P A A P P
32 Balaraman 751/04 20951 22 M 22% - Collagen 18 P* P A A P A
33 Kanthan 762/04 21342 25 M 17% Ointment - 14 A A A A P P
34 Nawaab 778/04 21867 35 M 10% Ointment - 16 A P A A P P
35 Karunakaran 791/04 22243 32 M 12% - Collagen 14 A A A A P P
36 Sivagami 799/04 22645 20 F 30% - Collagen 12 A A A A P P
Sl 
No. Name AB No. IP No. Age Sex %BSA Dressing CWH Inf
Morbidity
Pn Oz Sm EM DA
37 Komalavalli 807/04 22948 26 F 12% Ointment - 16 A P P A A P
38 Dilli Babu 819/04 23192 5 M 18% - Collagen ** P* P P P A A
39 Sujeetha 830/04 23564 20 F 26% - Collagen 14 A A A A P P
40 Ashok Kumar 841/04 23951 4 M 31% Ointment - 26 P P P P A A
41 Amul 857/04 24234 21 F 18% Ointment - 28 P P P P A A
42 Parimala 868/04 24685 32 F 13% - Collagen 12 A A A A P P
43 Mathivanan 879/04 24962 3 M 20% - Collagen 12 A A A A P P
44 Ramesh 891/04 25215 22 M 30% Ointment - ** P* P P P A A
45 Neelavathi 898/04 25496 25 F 18% - Collagen 14 A A A A P P
46 Ramu 906/04 25798 11 M 19% Ointment - 20 P P A P P A
47 Karuppiah 916/04 26004 35 M 14% - Collagen 16 A P A A P P
48 Babu Sekar 924/04 26289 38 M 10% Ointment - 24 P P P P A A
49 Sudha 939/04 26541 27 F 24% - Collagen 14 A A A A P P
50 Shakthi Banu 953/04 26983 24 F 30% - Collagen 16 A P A A P P
51 Devi 14/05 356 24 F 17% Ointment - 30 P P P P A A
52 Thilaga 26/05 543 25 F 35% - Collagen 14 A A A A P P
53 Selvaraj 34/05 856 35 F 12% Ointment - 24 P P P P P A
54 Sahul Hameed 47/05 1131 29 M 11% Ointment - 20 P P A P P A
55 Banu 59/05 1523 28 F 35% Ointment - 18 A A A P P P
56 George 74/05 2013 37 M 15% Ointment - 22 P P A P P A
57 Uma 76/05 2096 28 F 25% Ointment - 16 A P A A P P
58 Vinodh 88/05 2543 12 M 15% Ointment - 26 P P P A P A
59 Jabesa 98/05 2956 4 F 14% - Collagen 12 A A A A P P
60 Indira 106/05 3212 35 F 27% - Collagen 14 A A A A P P
61 Moses 121/05 3689 9 M 10% Ointment - 16 A P A A P P
62 Suriya 128/05 3956 22 F 18% Ointment - 14 A A A A P P
63 Padmini 138/05 4275 38 F 35% - Collagen 12 A P A A P P
64 Shanmugam 147/05 4738 25 M 29% - Collagen 14 A A A A P P
65 Anitha 155/05 5049 16 F 25% Ointment - 16 A P A A P P
66 Jayakumar 168/05 5568 9 M 22% - Collagen 14 A A A A P P
67 Baranidaran 181/05 5946 36 M 24% Ointment - 18 A P A A P P
68 Muthulakshmi 193/05 6326 17 F 24% - Collagen 14 A A A A P P
69 Devaraj 203/05 6714 37 M 25% Ointment - 16 A P A A P P
70 Sangeetha 214/05 6998 22 F 14% - Collagen 12 A A A A P P
71 Rizwana 221/05 7342 25 F 11% Ointment - 28 P P P P A A
72 Kalpana 229/05 7752 3 F 15% - Collagen 12 A A A A P P
73 Vijayakumar 235/05 7987 30 M 12% - Collagen 12 A P A A P P
74 Saraswathi 243/05 8205 37 F 10% Ointment - 24 P P P A P A
75 Lakshmi 254/05 8512 30 F 29% - Collagen 14 A A A A P P
Sl 
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76 Vanitha 262/05 8883 19 F 27% - Collagen 14 A A A A P P
77 Nagarajan 275/05 9005 29 M 10% Ointment - 26 P P P A P A
78 Rekha 283/05 9346 22 F 19% - Collagen 12 A A A A P P
79 Vennila 296/05 9676 20 F 23% - Collagen 14 A A A A P P
80 Chandrasekar 302/05 9856 25 M 17% Ointment - 16 A P A A P A
81 Suriya 316/05 10223 20 F 19% - Collagen 12 A A A A P P
82 Kalyani 329/05 10678 35 F 17% Ointment - 22 P P A P P A
83 Sureka 338/05 10978 35 F 18% Ointment - 16 A P A A P P
84 Girija 346/05 11143 32 F 35% - Collagen 14 A A A A P P
85 Vignesh 354/05 11412 2 M 13% Ointment  18 A P A A P P 7
86 Viswanathan 364/05 11706 28 M 26% - Collagen 12 A A A A P P 1
87 Baskaran 371/05 11958 34 M 18% Ointment - 16 A P A A P P 7
88 Uma 385/05 12265 19 F 16% Ointment - 24 P P A P P A 11
89 Nirmala 393/05 12512 20 F 25% - Collagen 14 A A A A P P 1
90 Veeraperumal 402/05 12864 23 M 30% - Collagen 12 A A A A P P 1
91 Radha 415/05 13142 20 F 25% Ointment - 26 P P A A P P 10
92 Vadivu 426/05 13546 38 F 25% - Collagen 12 A A A A P P 1
93 Raja 439/05 13891 38 M 10% - Collagen 10 A A A A P P 1
94 Devika 451/05 14124 24 F 23% Ointment - 20 P P A P P A 9
95 Kalyani 459/05 14356 22 F 36% - Collagen 12 A A A A P P 1
96 Dhanalakshmi 465/05 14625 32 F 23% Ointment - 18 P P A A P P 9
97 Karthika 471/05 14876 17 F 14% Ointment - 26 P P P P P A 12
98 Rasool Beevi 478/05 15042 28 F 37% - Collagen 14 A P A A P P 1
99 Sushmitha 497/05 15345 11 F 32% Ointment - 20 P P A P P P 9
100 Gopinath 503/05 15875 15 M 22% Ointment - 16 A P A A P P 7
